World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
36446
World Ranking
12977
National Ranking
6634

Overview

Lawrence F. Eichenfield is affiliated with the University of California, San Diego in the United States. Their research primarily focuses on the fields of Medicine, with a significant concentration on Dermatology and Immunology and Allergy. Their work also spans related subfields including Physiology, Biotechnology, and Rheumatology.

Eichenfield's research covers multiple topics with considerable publication counts in areas such as Dermatology and Skin Diseases, Allergic Rhinitis and Sensitization, Food Allergy and Anaphylaxis Research, Asthma and respiratory diseases, Transgenic Plants and Applications, Acne and Rosacea Treatments and Effects, and Urticaria and Related Conditions.

Frequent publication venues for Eichenfield include the Journal of the American Academy of Dermatology, British Journal of Dermatology, SKIN The Journal of Cutaneous Medicine, Journal of Drugs in Dermatology, and Journal of Investigative Dermatology.

The scientist has collaborated extensively with several notable coauthors, including:

  • Amy S. Paller
  • Eric L. Simpson
  • Jonathan I. Silverberg
  • Linda Stein Gold
  • Adelaide A. Hebert

Recent papers authored or coauthored by Lawrence F. Eichenfield include:

  • Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials, 2020, British Journal of Dermatology
  • Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis, 2020, JAMA Dermatology
  • Management of Acne Vulgaris, 2021, JAMA
  • Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis, 2020, JAMA Dermatology
  • Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies, 2021, Journal of the American Academy of Dermatology

Best Publications

  • Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report

    Joshua A. Boyce;Amal Assa'ad;A. Wesley Burks;Stacie M. Jones

  • Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies

    Lawrence F. Eichenfield;Lawrence F. Eichenfield;Wynnis L. Tom;Wynnis L. Tom;Timothy G. Berger;Alfons Krol

  • Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

    Lawrence F. Eichenfield;Wynnis L. Tom;Sarah L. Chamlin;Steven R. Feldman

  • Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel

    Alkis Togias;Susan F. Cooper;Maria L. Acebal;Amal Assa'ad

  • Guidelines of care for the management of atopic dermatitis: Section 3. Management and treatment with phototherapy and systemic agents

    Robert Sidbury;Dawn M. Davis;David E. Cohen;Kelly M. Cordoro

  • Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults

    Amy S. Paller;Wynnis L. Tom;Wynnis L. Tom;Mark G. Lebwohl;Robin L. Blumenthal

  • Etanercept treatment for children and adolescents with plaque psoriasis.

    Amy S. Paller;Elaine C. Siegfried;Richard G. Langley;Alice B. Gottlieb

  • Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

    Lawrence F. Eichenfield;Anne W. Lucky;Mark Boguniewiczc;Richard G.B. Langley

  • A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients.

    Amy Paller;Lawrence F. Eichenfield;Donald Y.M. Leung;Daniel Stewart

  • Consensus conference on pediatric atopic dermatitis

    Lawrence F. Eichenfield;Jon M. Hanifin;Thomas A. Luger;Seth R. Stevens

  • Altered proliferation and networks in neural cells derived from idiopathic autistic individuals

    Maria C Marchetto;Haim Belinson;Yuan Tian;Beatriz C Freitas

  • Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

    Eric L. Simpson;J.‐P. Lacour;L. Spelman;R. Galimberti

  • Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches

    Robert Sidbury;Wynnis L. Tom;James N. Bergman;Kevin D. Cooper

  • Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE).

    Eric L. Simpson;Carsten Flohr;Lawrence F. Eichenfield;Thomas Bieber

  • Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne

    Lawrence F. Eichenfield;Lawrence F. Eichenfield;Andrew C. Krakowski;Andrew C. Krakowski;Caroline Piggott;Caroline Piggott;James Del Rosso

  • A clinical study to evaluate the efficacy of ELA-Max (4% liposomal lidocaine) as compared with eutectic mixture of local anesthetics cream for pain reduction of venipuncture in children.

    Lawrence F Eichenfield;Ann Funk;Sheila Fallon-Friedlander;Bari B Cunningham

  • Guidelines of care for hemangiomas of infancy

    Ilona J Frieden;Lawrence F Eichenfield;Nancy B Esterly;Roy Geronemus

  • Atopic dermatitis and asthma: Parallels in the evolution of treatment

    Lawrence F. Eichenfield;Jon M. Hanifin;Lisa A. Beck;Robert F. Lemanske

  • Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial

    Emma Guttman-Yassky;Andrew Blauvelt;Lawrence F. Eichenfield;Lawrence F. Eichenfield;Amy S. Paller

  • Management of Atopic Dermatitis in the Pediatric Population

    Andrew C. Krakowski;Lawrence F. Eichenfield;Lawrence F. Eichenfield;Magdalene A. Dohil

Frequent Co-Authors

Amy S. Paller
Amy S. Paller Northwestern University
Eric L. Simpson
Eric L. Simpson Oregon Health & Science University
Lisa A. Beck
Lisa A. Beck University of Rochester Medical Center
Mark Boguniewicz
Mark Boguniewicz National Jewish Health
Glenn T. Furuta
Glenn T. Furuta University of Colorado Denver
Jon M. Hanifin
Jon M. Hanifin Oregon Health & Science University
Hugh A. Sampson
Hugh A. Sampson Icahn School of Medicine at Mount Sinai
Ilona J. Frieden
Ilona J. Frieden University of California, San Francisco
Jonathan M. Spergel
Jonathan M. Spergel University of Pennsylvania
Lynda C. Schneider
Lynda C. Schneider Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can help broaden your career options and make entering the field more accessible. Many students begin their journey toward working in Medicine by considering nursing degrees, such as affordable rn to bsn programs. These online options allow registered nurses to earn their bachelor’s degree faster and at a lower cost, giving you flexibility if you’re already working.

For those wanting to advance their skills or change careers, look into direct entry msn programs. These are designed for non-nurses who hold a bachelor’s degree in another field and want to quickly earn a master’s in nursing.

Admission competitiveness can also vary. If your focus is on access, some of the easiest bsn program to get into options offer more flexible requirements, helping students from diverse backgrounds start a healthcare career sooner.

If you’re interested in the administrative side, there are many reputable medical billing and coding online schools that accept financial aid. These programs are ideal if you want a healthcare role that doesn’t require direct patient care but still makes a big impact.

Best Scientists Citing Lawrence F. Eichenfield

Trending Scientists

Recently Published Articles